Consulting Services
For Investors
Products
Case Studies
Insights

Contact Us

Search

Diabetic macular edema

EURETINA 2026 preview covering retinal gene therapy, Eylea 8 mg, geographic atrophy treatments and AI in retinal imaging.

EURETINA 2026 Preview: Key Retinal Therapy Trends and Competitive Developments

Euretina 2026 at a glance At EURETINA 2026, retinal competition is increasingly…

Rare Disease news

Rare Diseases Today—May 14, 2026

This week’s Rare Diseases update highlights clinical progress, manufacturing…

Cell_Gene_Therapy

Cell and Gene Therapy Today—November 20, 2025

This weekly Cell & Gene Therapy update spans regulatory actions, durable…

EURETINA 2025 Preview: Key Retinal Disease Highlights to Watch

EURETINA 2025 at a glance Looking ahead to EURETINA 2025, LucidQuest outlines…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
LucidScope AI Audit Analyses
Public Health News
Monthly Strategic Roundups
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

ESGCT 2026 Preview: Gene and Cell Therapy Trends
ESMO 2026 Preview: Oncology Innovations, Clinical Trials and AI
Hematology Strategic Roundup: Earlier-Line Therapies and Competitive Shifts | Sep 18 – Oct 22, 2026
Georgiamune and Menarini Sign $1.1B GIM-621 Licensing Deal | Lucid Diligence Brief
Rare Diseases Strategic Roundup: From Scientific Breakthroughs to Patient Access | Sep 16- Oct 12, 2026

Tags

alnodesertib Baricitinib Breast Arterial Calcification Caranx Medical CardioAI CareSens Air Cleveland Clinic Cleveland Clinic Cole Eye Institute Dr. Reddy’s Eli Lilly Zepbound emerging viruses ENFLONSIA ESO-T01 Glucocorticoid-Induced Osteoporosis Google Research HPV-Negative Head And Neck Cancer HSK51155 hypertrophic cardiomyopathy Iclusig icovamenib KOMET-001 leukemia CSR Lifyorli Lira-Cel Malignant glioma microbiome biomarkers Moligo Technologies neuroendocrine tumors NICHE NV-387 Oculis omalizumab biosimilar OPN-6602 Pediatric Malignant Glioma ReCode Therapeutics respiratory syncytial virus Sanofi Ventures SCN2A Short Bowel Syndrome SIM0505 Structural heart disease Tegoprazan TNX-1900 VIR-5500 Vivoo app

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

ESGCT 2026 Preview: Gene and Cell Therapy Trends
ESMO 2026 Preview: Oncology Innovations, Clinical Trials and AI
Hematology Strategic Roundup: Earlier-Line Therapies and Competitive Shifts | Sep 18 – Oct 22, 2026
Georgiamune and Menarini Sign $1.1B GIM-621 Licensing Deal | Lucid Diligence Brief
Rare Diseases Strategic Roundup: From Scientific Breakthroughs to Patient Access | Sep 16- Oct 12, 2026

TAGS

alnodesertib Baricitinib Breast Arterial Calcification Caranx Medical CardioAI CareSens Air Cleveland Clinic Cleveland Clinic Cole Eye Institute Dr. Reddy’s Eli Lilly Zepbound emerging viruses ENFLONSIA ESO-T01 Glucocorticoid-Induced Osteoporosis Google Research HPV-Negative Head And Neck Cancer HSK51155 hypertrophic cardiomyopathy Iclusig icovamenib KOMET-001 leukemia CSR Lifyorli Lira-Cel Malignant glioma microbiome biomarkers Moligo Technologies neuroendocrine tumors NICHE NV-387 Oculis omalizumab biosimilar OPN-6602 Pediatric Malignant Glioma ReCode Therapeutics respiratory syncytial virus Sanofi Ventures SCN2A Short Bowel Syndrome SIM0505 Structural heart disease Tegoprazan TNX-1900 VIR-5500 Vivoo app

Consulting Services
For Investors
Products
Case Studies
Insights

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy